Literature DB >> 15870379

Role of cytochrome B5 in modulating peroxide-supported cyp3a4 activity: evidence for a conformational transition and cytochrome P450 heterogeneity.

Santosh Kumar1, Dmitri R Davydov, James R Halpert.   

Abstract

The role of cytochrome b(5) (b(5)) in the alpha-naphthoflavone (alpha-NF)-mediated inhibition of H(2)O(2)-supported 7-benzyloxyquinoline (7-BQ) debenzylation by heterologously expressed and purified cytochrome P450 3A4 (CYP3A4) was studied. Although alpha-NF showed negligible effect in an NADPH-dependent reconstituted system, inhibition of 7-BQ oxidation was observed in the H(2)O(2) system. Analysis of the effect of various constituents of a standard reconstituted system on H(2)O(2)-supported activity showed that b(5) alone resulted in a 2.5-fold increase in the k(cat) value and reversed the inhibitory effect of alpha-NF. In addition, titration with b(5) suggested that only 65% of the CYP3A4 participated in the interaction with b(5), consistent with cytochrome P450 (P450) heterogeneity. Study of the influence of b(5) on the kinetics of H(2)O(2)-dependent destruction of the P450 heme moiety suggested two distinct conformers of CYP3A4 with different sensitivity to heme loss. In the absence of b(5), 66% of the wild-type enzyme was bleached in the fast phase, whereas the addition of b(5) decreased the fraction of the fast phase to 16%. Finally, to locate amino acid residues that might influence b(5) action, several active site mutants were tested. Substitution of Ser-119, Ile-301, Ala-305, Ile-369, or Ala-370 with the larger Phe or Trp decreased or even abolished the activation by b(5). Ser-119 is in the B'-C loop, a predicted b(5)-P450 interaction site, and Ile-301 and Ala-305 are closest to the heme. In conclusion, the interaction of b(5) with P450 apparently leads to a conformational transition, which results in redistribution of the CYP3A4 pool.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870379     DOI: 10.1124/dmd.105.004606

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  16 in total

1.  Re-engineering cytochrome P450 2B11dH for enhanced metabolism of several substrates including the anti-cancer prodrugs cyclophosphamide and ifosfamide.

Authors:  Ling Sun; Chong S Chen; David J Waxman; Hong Liu; James R Halpert; Santosh Kumar
Journal:  Arch Biochem Biophys       Date:  2007-01-08       Impact factor: 4.013

Review 2.  Allosteric P450 mechanisms: multiple binding sites, multiple conformers or both?

Authors:  Dmitri R Davydov; James R Halpert
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-12       Impact factor: 4.481

3.  Role of subunit interactions in P450 oligomers in the loss of homotropic cooperativity in the cytochrome P450 3A4 mutant L211F/D214E/F304W.

Authors:  Harshica Fernando; Dmitri R Davydov; Christopher C Chin; James R Halpert
Journal:  Arch Biochem Biophys       Date:  2007-01-12       Impact factor: 4.013

Review 4.  Current Approaches for Investigating and Predicting Cytochrome P450 3A4-Ligand Interactions.

Authors:  Irina F Sevrioukova; Thomas L Poulos
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

5.  Specific packaging and circulation of cytochromes P450, especially 2E1 isozyme, in human plasma exosomes and their implications in cellular communications.

Authors:  Santosh Kumar; Namita Sinha; Kelli A Gerth; Mohammad A Rahman; Murali M Yallapu; Narasimha M Midde
Journal:  Biochem Biophys Res Commun       Date:  2017-07-26       Impact factor: 3.575

6.  Mechanism of interactions of alpha-naphthoflavone with cytochrome P450 3A4 explored with an engineered enzyme bearing a fluorescent probe.

Authors:  Tamara N Tsalkova; Nadezhda Y Davydova; James R Halpert; Dmitri R Davydov
Journal:  Biochemistry       Date:  2007-01-09       Impact factor: 3.162

7.  Cytochrome P450 17A1 Interactions with the FMN Domain of Its Reductase as Characterized by NMR.

Authors:  D Fernando Estrada; Jennifer S Laurence; Emily E Scott
Journal:  J Biol Chem       Date:  2015-12-30       Impact factor: 5.157

8.  Differential effects of ethanol on spectral binding and inhibition of cytochrome P450 3A4 with eight protease inhibitors antiretroviral drugs.

Authors:  Santosh Kumar; Anil Kumar
Journal:  Alcohol Clin Exp Res       Date:  2011-06-17       Impact factor: 3.455

9.  Experimental approaches to evaluate activities of cytochromes P450 3A.

Authors:  Lucie Bořek-Dohalská; Petr Hodek; Jiří Hudeček; Marie Stiborová
Journal:  Interdiscip Toxicol       Date:  2008-09

10.  Explaining the atypical reaction profiles of heme enzymes with a novel mechanistic hypothesis and kinetic treatment.

Authors:  Kelath Murali Manoj; Arun Baburaj; Binoy Ephraim; Febin Pappachan; Pravitha Parapurathu Maviliparambathu; Umesh K Vijayan; Sivaprasad Valiyaveettil Narayanan; Kalaiselvi Periasamy; Ebi Ashley George; Lazar T Mathew
Journal:  PLoS One       Date:  2010-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.